[ad_1]
LUXEMBOURG–(BUSINESS WIRE)–Eurofins CDMO Alphora Inc. announces that it has received its Health Canada Cannabis Drug License issued within the Cannabis Act and Cannabis Regulations for its Oakville, Ontario operations in September 2023. This compliments the Institutional Research License obtained through Health Canada in June 2021 for its Mississauga development site and a Standard Processing License obtained for the Oakville, Ontario manufacturing operation in May 2022. With the new Cannabis
[ad_2]
Source link
Health Canada Approves Eurofins CDMO Alphora Inc.’s Cannabis Drug License for Synthetic Phytocannabinoids
-
PreviousVirpax Pharmaceuticals Announces Extension of CRADA with the U.S. Army Institute of Surgical Research
-
NextGlobal Vending Machine Operators Market Report 2023-2027 & 2032: Leading Companies are Looking to Exploit Cashless Payments, IoT, Artificial Intelligence, and Big Data Analytics to Boost Sales – ResearchAndMarkets.com
